Medications

Cholesterol-lowering statins prescribed less later in day

Furthering efforts to understand why potentially life-saving statins are so under-prescribed among American patients with heart disease, a new study shows that clinicians are more likely to sign a script for them earlier ...

Oncology & Cancer

Cholesterol levels, not statins, influence colorectal cancer risk

Long-term use of the cholesterol-lowering drugs known as statins does not appear to decrease a patient's risk of colorectal cancer, suggests a new, large case-control study from Penn Medicine researchers published this week ...

Cardiology

New patient-centered recommendations for cholesterol management

The National Lipid Association (NLA) has released new recommendations for the prevention of heart disease and stroke. Published recently in the Journal of Clinical Lipidology, the guidelines emphasize a "patient-centered" ...

Cardiology

Study shows who benefits most from statins

New research suggests that widely used statin therapy provides the most benefit to patients with the highest genetic risk of heart attack. Using a relatively straightforward genetic analysis, the researchers assessed heart ...

Diseases, Conditions, Syndromes

USPSTF updates guidance on statins for primary prevention of CVD

The U.S. Preventive Services Task Force (USPSTF) recommends statins for the primary prevention of cardiovascular disease (CVD) for adults aged 40 to 75 years who have cardiovascular risk factors, with the strength of recommendation ...

Diseases, Conditions, Syndromes

Statin use found beneficial in hepatitis C treatment

(HealthDay)—For patients with hepatitis C virus (HCV), statin therapy is associated with improved virologic response rates, as well as decreased liver fibrosis progression and hepatocellular carcinoma (HCC) incidence, according ...

page 1 from 14